What is the Solution?

Biotech startup Tiamat produces affordable animal-free proteins, using a proprietary plant molecular farming platform. By bringing together molecular biology, vertical farming and a data-driven approach, Tiamat manufactures animal-free proteins that can replace costly bioreactors. Those reinvented proteins can be used in a number of different areas such as cellular agriculture, regenerative medicine, and novel vaccine production. With substantially lower production costs, the Tiamat proteins can be offered about 10 times cheaper than the current market offers with fermentation technologies. As Tiamat scales up, the team believes they can achieve production 1,000 times cheaper by 2025 as a starting point for a much bigger scale to enable the new era of biomanufacturing.

Plants are crucial to achieve sustainable biomanufacturing, as they provide quantities of product created in less than four weeks. The proteins can be offered at a reduced cost, using less water and energy, and fully compostable. In today’s economy, it is difficult to find animal-free alternatives in products such as clothing and medicines, many of which today are made with animal-based reagents. Tiamat’s plants define a new standard in safety and sustainability, providing growth factors, cytokines, enzymes, and high-value and animal-free proteins.